Apoptosis inducing factor and PARP-mediated injury in the MPTP mouse model of Parkinson's disease

Annals of the New York Academy of Sciences

Volumn 991, Issue , 2003, Pages 132-139

  Wang, Hongmin ^a   Shimoji, Mika ^a   Yu, Seong Woon ^a   Dawson, Ted M ^a   Dawson, Valina L ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Neurology ^*  (United States)

Author keywords

Apoptosis inducing factor; MPTP mouse model; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ALPHA SYNUCLEIN; APOPTOSIS INDUCING FACTOR; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTOXIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN INJURY; CELL DEATH; CONFERENCE PAPER; CONTROLLED STUDY; DNA DAMAGE; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; GENE MUTATION; INTOXICATION; LEWY BODY; MOLECULAR MECHANICS; MOUSE; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; SUBSTANTIA NIGRA;

ANIMALIA; MAMMALIA;

EID: 0037713529     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2003.tb07471.x     Document Type: Conference Paper

References (44)

1. DAWSON, T.M. 2000. New animal models for Parkinson's disease. Cell 101: 115-118.
2. LANG, A.E. & A.M. LOZANO. 1998. Parkinson's disease. First of two parts. N. Engl. J. Med. 339: 1044-1053.
3. LANG, A.E. & A.M. LOZANO. 1998. Parkinson's disease. Second of two parts. N. Engl. J. Med. 339: 1130-1143.
4. LEE, C.S., M. SCHULZER, E.K. MAK, et al. 1994. Clinical observations on the rate of progression of idiopathic parkinsonism. Brain 117: 501-507.
5. DAWSON, V.L. & T.M. DAWSON. 1996. Nitric oxide neurotoxicity. J. Chem. Neuroanat. 10: 179-190.
6. FORNO, L.S., J.W. LANGSTON, L.E. DELANNEY, et al. 1986. Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys. Ann. Neurol. 20: 449-455.
7. MIZUNO, Y., N. SONE & T. SAITOH. 1987. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4- phenylpyridinium ion on activities of the enzymes in the electron transport system in mouse brain. J. Neurochem. 48: 1787-1793.
8. DEXTER, D.T., I. NANAYAKKARA, M.A. GOSS-SAMPSON, et al. 1994. Nigral dopaminergic cell loss in vitamin E deficient rats. Neuroreport 5: 1773-1776.
9. SCHAPIRA, A.H. 1996. Neurotoxicity and the mechanisms of cell death in Parkinson's disease. Adv. Neurol. 69: 161-165.
10. LANGSTON, J.W. 1996. The etiology of Parkinson's disease with emphasis on the MPTP story. Neurology 47: S153-160.
11. HEIKKILA, R.E., B.A. SIEBER, L. MANZINO & P.K. SONSALLA. 1989. Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse. Mol. Chem. Neuropathol. 10: 171-183.
12. TURSKI, L., K. BRESSLER, K.J. RETTIG, et al. 1991. Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D- aspartate antagonists. Nature 349: 414-418.
13. SONSALLA, P.K., D.S. ALBERS & G.D. ZEEVALK. 1998. Role of glutamate in neurodegeneration of dopamine neurons in several animal models of parkinsonism. Amino Acids 14: 69-74.
14. BEAL, M.F. 1998. Excitotoxicity and nitric oxide in Parkinson's disease pathogenesis. Ann. Neurol. 44: S110-114.
15. SHERER, T.B., R. BETARBET & J.T. GREENAMYRE. 2001. Pathogenesis of Parkinson's disease. Curr. Opin. Investig. Drugs 2: 657-662.
16. JUAREZ-SALINAS, H., J.L. SIMS & M.K. JACOBSON. 1979. Poly(ADP-ribose) levels in carcinogen-treated cells. Nature 282: 740-741.
17. BENJAMIN, R.C. & D.M. GILL. 1980. Poly(ADP-ribose) synthesis in vitro programmed by damaged DNA. A comparison of DNA molecules containing different types of strand breaks. J. Biol. Chem. 255: 10502-10508.
18. MILAM, K.M. & J.E. CLEAVER. 1984. Inhibitors of poly(adenosine diphosphate-ribose) synthesis: effect on other metabolic processes. Science 223: 589-591.
19. BERGER, N.A. 1985. Poly(ADP-ribose) in the cellular response to DNA damage. Radiat. Res. 101: 4-15.
20. THRAVES P.J., U. KASID & M.E. SMULSON. 1985. Selective isolation of domains of chromatin proximal to both carcinogen-induced DNA damage and poly-adenosine diphosphate-ribosylation. Cancer Res. 45: 386-391.
21. SZABO, C. & V.L. DAWSON. 1998. Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol. Sci. 19: 287-298.
22. YU, S.W., H. WANG, M.F. POITRAS, et al. 2002. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 297: 259-263.
23. PIFL, C., B. GIROS & M.G. CARON. 1993. Dopamine transporter expression confers cytotoxicity to low doses of the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium. J. Neurosci. 13: 4246-4253.
24. DUNNETT, S.B. & A. BJORKLUND. 1999. Prospects for new restorative and neuroprotective treatments in Parkinson's disease. Nature 399: A32-39.
25. RAMSAY, R.R., S.O. SABLIN, S.O. BACHURIN & T.P. SINGER. 1993. Oxidation of tetrahydrostilbazole by monoamine oxidase A demonstrates the effect of alternate pathways in the kinetic mechanism. Biochemistry 32: 9025-9030.
26. BLUM, D., S. TORCH, M.F. NISSOU & J.M. VERNA. 2001. 6-Hydroxydopamine-induced nuclear factor-kappa B activation in PC12 cells. Biochem. Pharmacol. 62: 473-481.
27. BECKMAN, J.S. & J.P. CROW. 1993. Pathological implications of nitric oxide, superoxide and peroxynitrite formation. Biochem. Soc. Trans. 21: 330-334.
28. PRZEDBORSKI, S., V. JACKSON-LEWIS, R. YOKOYAMA, et al. 1996. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc. Natl. Acad. Sci. USA 93: 4565-4571.
29. RADONS, J., B. HELLER, A. BURKLE, et al. 1994. Nitric oxide toxicity in islet cells involves poly(ADP-ribose) polymerase activation and concomitant NAD+ depletion. Biochem. Biophys. Res. Commun. 199: 1270-1277.
30. ZHANG, J., V.L. DAWSON, T.M. DAWSON & S.H. SNYDER. 1994. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 263: 687-689.
31. MANDIR, A.S., S. PRZEDBORSKI, V. JACKSON-LEWIS, et al. 1997. Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism. Proc: Natl. Acad. Sci. USA 96: 5774-5779.
32. CHIARUGI, A. & M.A. MOSKOWITZ. 2002. Cell biology. PARP-1 - a perpetrator of apoptotic cell death? Science 297: 200-201.
33. TATTON, N.A. & S.J. KISH. 1997. In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining. Neuroscience 77: 1037-1048.
34. COSI, C., F. COLPAERT, W. KOEK, et al. 1996. Poly(ADP-ribose) polymerase inhibitors protect against MPTP-induced depletions of striatal dopamine and cortical noradrenaline in C57B1/6 mice. Brain Res. 729: 264-269.
35. COSI, C., H. SUZUKI, S.D. SKAPER, et al. 1997. Poly(ADP-ribose) polymerase (PARP) revisited. A new role for an old enzyme: PARP involvement in neurodegeneration and PARP inhibitors as possible neuroprotective agents. Ann. N.Y. Acad. Sci. 825: 366-379.
36. COSI, C. & M. MARIEN. 1999. Decreases in mouse brain NAD+ and ATP induced by 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP): prevention by the poly(ADP-ribose) polymerase inhibitor, benzamide. Brain Res. 809: 58-67.
37. COSI, C. & M. MARIEN. 1999. Implication of poly (ADP-ribose) polymerase (PARP) in neurodegeneration and brain energy metabolism. Decreases in mouse brain NAD+ and ATP caused by MPTP are prevented by the PARP inhibitor benzamide. Ann. N.Y. Acad. Sci. 890: 227-239.
38. MANDIR, A.S., M.F. POITRAS, A.R. BERLINER, et al. 2000. NMDA but not non-NMDA excitotoxicity is mediated by Poly(ADP-ribose) polymerase. J. Neurosci. 20: 8005-8011.
39. SUSIN, S.A., H.K. LORENZO, N. ZAMZAMI, et al. 1999. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397: 441-446.
40. DAUGAS, E., S.A. SUSIN, N. ZAMZAMI, et al. 2000. Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis. FASEB J. 14: 729-739.
41. JOZA, N., S.A. SUSIN, E. DAUGAS, et al. 2001. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 410: 549-554.
42. WANG, H., S.W. YU, M.F. POITRAS, et al. 2001. Translocation of apoptosis-inducing factor is involved in NMDA excitotoxicity and is poly(ADP-ribose) polymerase dependent. Abstr. Soc. Neurosci. 96.16.
43. WANG, H., S.W. YU, M.F. POITRAS, et al. 2002. Apoptosis-inducing factor mediates poly(ADP-ribose) polymerase-1 dependent NMDA excitotoxicity. Abstr. Soc. Neurosci. 199.4.
44. SHIMOJI, M., L. ZHANG, A.S. MANDIR, et al. 2002. Investigation of inclusion body formation in the MPTP mouse model of Parkinson's disease. Abstr. Soc. Neurosci. 485.8.